Caramel: Dual-targeting (CD123/CD33) CAR-T cell as a bridge to allogeneic transplantation for Relapsed/Refractory Acute Myeloid Leukemia. preclinical Results.


Por: Zugasti, I, Mulens-Arias, V, Espinosa-Aroca, L, Vinyoles, M, Martinez-Moreno, A, Roca-Ho, H, Rodriguez-Cortez, V, Engel, P, Albiol, N, Martinez-Cibrian, N, Oliver-Caldes, A, Ortiz-Maldonado, V, Cortés-Bullich, A, Castaño-Díez, S, Cardus, A, Jimenez-Vicente, C, Guijarro, F, Martinez-Roca, A, Rodriguez-Sevilla, JJ, Díaz-Beyá, M, Gonzalez, JD, Urbano-Ispizua, A, Esteve, J, Menéndez, P and Velasco-Hernandez, T

Publicada: 1 dic 2025 Ahead of Print: 1 dic 2025
Resumen:


Filiaciones:
Zugasti, I:
 Hosp Clin Barcelona, Hematol Dept, ICAMS, Barcelona, Spain

 August Pi i Sunyer Biomed Res Inst IDIBAPS, Barcelona, Spain

:
 Josep Carreras Leukaemia Res Inst, Sch Med, Stem Cell Biol Dev Leukemia & Immunotherapy Lab, Barcelona 08036, Spain

:
 Josep Carreras Leukaemia Res Inst, Sch Med, Stem Cell Biol Dev Leukemia & Immunotherapy Lab, Barcelona 08036, Spain

:
 Josep Carreras Leukaemia Res Inst, Sch Med, Stem Cell Biol Dev Leukemia & Immunotherapy Lab, Barcelona 08036, Spain

:
 Josep Carreras Leukaemia Res Inst, Sch Med, Stem Cell Biol Dev Leukemia & Immunotherapy Lab, Barcelona 08036, Spain

:
 Josep Carreras Leukaemia Res Inst, Sch Med, Stem Cell Biol Dev Leukemia & Immunotherapy Lab, Barcelona 08036, Spain

Rodriguez-Cortez, V:
 Josep Carreras Leukaemia Res Inst, Sch Med, Stem Cell Biol Dev Leukemia & Immunotherapy Lab, Barcelona 08036, Spain

Engel, P:
 Univ Barcelona, Dept Biomed Sci, Immunol Unit, Barcelona 08036, Spain

Albiol, N:
 Hosp Clin Barcelona, Hematol Dept, ICAMS, Barcelona, Spain

Martinez-Cibrian, N:
 Hosp Clin Barcelona, Hematol Dept, ICAMS, Barcelona, Spain

Oliver-Caldes, A:
 Hosp Clin Barcelona, Hematol Dept, ICAMS, Barcelona, Spain

Ortiz-Maldonado, V:
 Hosp Clin Barcelona, Hematol Dept, ICAMS, Barcelona, Spain

Cortés-Bullich, A:
 Hosp Clin Barcelona, Hematol Dept, ICAMS, Barcelona, Spain

 August Pi i Sunyer Biomed Res Inst IDIBAPS, Barcelona, Spain

Castaño-Díez, S:
 Hosp Clin Barcelona, Hematol Dept, ICAMS, Barcelona, Spain

 August Pi i Sunyer Biomed Res Inst IDIBAPS, Barcelona, Spain

Cardus, A:
 August Pi i Sunyer Biomed Res Inst IDIBAPS, Barcelona, Spain

Jimenez-Vicente, C:
 Hosp Clin Barcelona, Hematol Dept, ICAMS, Barcelona, Spain

 August Pi i Sunyer Biomed Res Inst IDIBAPS, Barcelona, Spain

Guijarro, F:
 Hosp Clin Barcelona, Hematol Dept, ICAMS, Barcelona, Spain

 Josep Carreras Leukaemia Res Inst, Sch Med, Stem Cell Biol Dev Leukemia & Immunotherapy Lab, Barcelona 08036, Spain

Martinez-Roca, A:
 Hosp Clin Barcelona, Hematol Dept, ICAMS, Barcelona, Spain

 August Pi i Sunyer Biomed Res Inst IDIBAPS, Barcelona, Spain

Rodriguez-Sevilla, JJ:
 Hosp Clin Barcelona, Hematol Dept, ICAMS, Barcelona, Spain

 August Pi i Sunyer Biomed Res Inst IDIBAPS, Barcelona, Spain

Díaz-Beyá, M:
 Hosp Clin Barcelona, Hematol Dept, ICAMS, Barcelona, Spain

 Univ Barcelona, Dept Biomed Sci, Immunol Unit, Barcelona 08036, Spain

Gonzalez, JD:
 August Pi i Sunyer Biomed Res Inst IDIBAPS, Barcelona, Spain

Urbano-Ispizua, A:
 Hosp Clin Barcelona, Hematol Dept, ICAMS, Barcelona, Spain

Esteve, J:
 Hosp Clin Barcelona, Hematol Dept, ICAMS, Barcelona, Spain

 August Pi i Sunyer Biomed Res Inst IDIBAPS, Barcelona, Spain

:
 Josep Carreras Leukaemia Res Inst, Sch Med, Stem Cell Biol Dev Leukemia & Immunotherapy Lab, Barcelona 08036, Spain

Velasco-Hernandez, T:
 Univ Barcelona, Dept Biomed Sci, Immunol Unit, Barcelona 08036, Spain
ISSN: 00064971





Blood
Editorial
American Society of Hematology, 2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA, Estados Unidos America
Tipo de documento: Meeting Abstract
Volumen: 146 Número:
Páginas: 7624-7625
WOS Id: 001669690900024

MÉTRICAS